Dr. Chambers is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3838 N Campbell Ave
Tucson, AZ 85719Phone+1 520-694-8888Fax+1 520-694-0348- Is this information wrong?
Education & Training
- Yale-New Haven Medical CenterFellowship, Gynecologic Oncology, 1984 - 1986
- Yale-New Haven Medical CenterResidency, Obstetrics and Gynecology, 1980 - 1984
- The Warren Alpert Medical School of Brown UniversityClass of 1980
Certifications & Licensure
- AZ State Medical License 2004 - 2026
- CT State Medical License 1984 - 2004
- IL State Medical License 1983 - 1984
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2008-2014
- Top Doctors:Arizona State Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2007-2013
- Join now to see all
Clinical Trials
- Effect of Flutamide on Biomarkers in Blood and Tissue Samples From Patients at High Risk of Ovarian Cancer Start of enrollment: 2005 Jan 01
- Alimta® Plus Cisplatin & Paclitaxel Given Intraperitonelly; First Line Tx Stage III Ovarian Cancer Start of enrollment: 2007 Sep 01
- Open Trial of Bendamustine Hydrochloride in Women With Advanced Ovarian Cancer Start of enrollment: 2009 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Antiandrogen Flutamide-Induced Restoration of miR-449 Expression Mitigates Functional Biomarkers Associated with Ovarian Cancer Risk.Xia Wang, Ho-Hyung Woo, Michele Wei, Steven Gibson, Mitzi Miranda, Demaretta Rush, Janiel Cragun, Wenxin Zheng, Guang Yao, Setsuko K Chambers> ;Medrxiv. 2024 Feb 29
- 1 citationsA phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chem...Robert W Holloway, Premal Thaker, Alberto A Mendivil, Sarfraz Ahmad, Ahmed N Al-Niaimi, James Barter, Tiffany Beck, Setsuko K Chambers, Robert L Coleman, Sarah M Craft...> ;International Journal of Gynecological Cancer. 2023 Sep 4
- 64 citationsNRF2 controls iron homeostasis and ferroptosis through HERC2 and VAMP8.Annadurai Anandhan, Matthew Dodson, Aryatara Shakya, Jinjing Chen, Pengfei Liu, Yongyi Wei, Hui Tan, Qian Wang, Ziyan Jiang, Kevin Yang, Joe Gn Garcia, Setsuko K Chamb...> ;Science Advances. 2023 Feb 3
- Join now to see all
Grant Support
- Regulation Of CSF-1 In Ovarian CancerNational Cancer Institute2004–2006
- Regulation Of CSF-1 In Ovarian CancerNational Cancer Institute2002–2003
- Regulation Of CSF 1 And Urokinase In Ovarian CancerNational Cancer Institute1995–1999
- Regulation Of C-FMS Proto-Oncogene In Epithelial CancersEunice Kennedy Shriver National Institute Of Child Health &Human Development1993–1995
- Contemporary Approaches To Ovarian CancerNational Cancer Institute1993
- CSF-1 And Drug Resistance In Reproductive CancersEunice Kennedy Shriver National Institute Of Child Health &Human Development1990–1991
Professional Memberships
- Fellow
Hospital Affiliations
- Banner - University Medical Center SouthTucson, Arizona
- Banner - University Medical Center TucsonTucson, Arizona
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: